Dr. Gayle Chapman

Director, Therapeutic Development

I am responsible for the delivery of our internal therapeutics development pipeline.

My expertise is in therapeutics discovery and development, from concept to clinic in pharmaceutical, biotech and virtual environments. My career spans 20+ years across all phases of therapeutics discovery from target identification through to early clinical trials (Phase I/II). I started as a cell and molecular biologist at SmithKline Beecham in their neuroscience department and have since worked as a team lead, head of function, project lead and portfolio lead in pharmaceutical companies (GSK/UCB/AZ/MedImmune) and biotech (Cambridge Antibody Technology, Celltech). More recently, I have held the role of VP R&D in a number of small VC funded biotechnology companies (E3Bio, HAF Ltd, RxCelerate). Through my own consultancy business, I have also had the opportunity to support progression of many different discovery/development projects across a range of therapeutic areas and modalities.